Medical Policy

D-1169-003

Policy Id

HHO-DE-MP-1169

Topic

Diagnosis and Treatment of Male Sexual Dysfunction

Section

Reproductive Health

Effective Date

Jun 16, 2025

Issued Date

May 16, 2025

Last Revision Date

05/2025

Annual Review

06/2026

Prepared By

Katie O

DISCLAIMER

Highmark medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions.

POLICY STATEMENT

This policy provides information regarding the coverage of, as determined by applicable federal and/or state legislation. 

This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records.

The qualifications of the policy will meet the standards of the National Committee for Quality Assurance (NCQA) and the Delaware Department of Health and Social Services (DHSS) and all applicable state and federal regulations. 

Policy Position

Prior Authorization

Prior Authorization may be required. Please validate codes on the Prior Authorization Lookup Tool https://www.highmarkhealthoptions.com/providers/prior-auth-lookup

Procedures

Erectile dysfunction is defined as the inability to achieve a sufficient erection for satisfactory sexual performance. Erectile function requires competent arterial blood inflow as well as a reduction of venous blood outflow. Disease and other risk factors may affect the arterial and venous systems in a manner that impedes erectile function and may lead to erectile dysfunction.

Please not that Oral and topical pharmacological treatments are not addressed in this policy.

Diagnosis of Male Sexual Dysfunction

The following procedures and tests for the diagnosis of erectile dysfunction may be considered medically necessary:

  •    Comprehensive history and physical examination
  •      Lab tests for testosterone levels 
    • Abnormal testosterone levels may necessitate further endocrine testing for hypothalamus, pituitary, thyroid, and adrenal dysfunction

·       Nocturnal Penile Tumescence (NPT) testing 

  • NPT testing may be considered medically necessary when the following criteria are met:
    • Clinical evaluation, including history and physical examination, is unable to distinguish psychogenic from organic erectile dysfunction; and
    • Any identified medical disorders have been corrected. 
 
  • Types of NPT testing that may be considered medically necessary:
    •  Snap-Gauge Device; or
    •  RigiScan
 
  •  NPT testing using the RigiScan may be considered medically necessary only:
    •   When NPT testing is indicated; and
    • The results of Snap-Gauge testing are equivocal or inconclusive. 
  • All other indications for NPT are considered not medically necessary.

The following diagnostic procedures are considered not medically necessary, as these tests do not have any therapeutic value because spinal cord injury and other neurological deficits that may cause erectile dysfunction are typically identified during a comprehensive history and examination:

·       Corpora cavernosal electromyography

·       Dorsal nerve conduction latencies

·       Evoked potential measurements

Procedures and testing for erectile dysfunction not meeting the criteria as indicated in this policy is considered not medically necessary.

TREATMENT OF MALE SEXUAL DYSFUNCTION

The following treatments may be considered medically necessary for male sexual dysfunction:

  •   Vacuum constriction devices (e.g., ErecAid); or
  •   Vasodilator injection (e.g., papaverine, phentolamine, alprostadil); or
  •   Vasodilator suppository (e.g., alprostadil); or

Treatment of male sexual dysfunction not meeting the criteria as indicated in this policy is considered not medically necessary.

PENILE PROSTHESES AND EXTERNAL DEVICES

Treatment of male sexual dysfunction with an internal penile prosthesis or an external device may be considered medically necessary when EITHER of the following criteria is met:

  •    Erectile dysfunction is due to an organic disease or injury and is not psychological in nature; or
  •    There is failure, a contraindication or an intolerance to pharmacological therapy.

The surgical implantation of an internal penile prosthesis may be considered medically necessary when the above criteria have been met.

The removal of an internal penile prosthesis may be considered medically necessary for ANY ONE of the following indications:

  • Infection; or
  •  Mechanical failure; or
  • Urinary obstruction; or
  • Intractable pain.

Following the removal of an internal penile prosthesis it may be considered medically necessary for surgical re-implantation of an internal penile prosthetic device.

An external device or an internal penile prosthesis insertion or removal not meeting the criteria as indicated in this policy is considered not medically necessary.

PENILE REVASCULARIZATION

Penile revascularization may be considered medically necessary for the treatment of erectile dysfunction when ALL of the following criteria are met:

·       The individual presents with erectile dysfunction preceded by blunt perineal or pelvic trauma; and

·       The individual has erectile dysfunction that is secondary to a focal arterial occlusion, as evidenced by an arteriogram or duplex ultrasonography conclusive for focal arterial obstruction; and

·       There is no evidence of generalized vascular disease (e.g., diabetes mellitus, hypertension, coronary artery disease), Peyronie’s plaques, intracavernosal masses, nodules, or sensory neuropathy; and

·       There is evidence of normal corporeal venous function; and

·       Alternative nonsurgical treatment modalities have been fully explained to the individual, and the individual is determined to achieve spontaneous erections without the need for pharmacological, external, or internal support devices; and

·       The individual is not actively smoking.

Venous ligation performed as a treatment for erectile dysfunction is considered not medically necessary.

Penile revascularization not meeting the criteria as indicated in this policy is considered not medically necessary.

37788

Penile Revascularization, Artery, With Or Without Vein Graft.

37790

Penile Venous Occlusive Procedure.

51792

Stimulus Evoked Response (e.g., Measurement Of Bulbocavernosus Reflex Latency Time).

54115

Removal Foreign Body From Deep Penile Tissue (e.g., Plastic Implant).

54230

Injection Procedure For Corpora Cavernosography.

54231

Dynamic cavernosometry, including intracavernosal injection of vasoactive drugs(eg, papaverine, phentolamine)

54235

Injection of corpora cavernosa with pharmacologic agent(s) (eg, papaverine, phentolamine)

 

54240

Penile plethysmography

 

54250

Nocturnal penile tumescene and/or rigidity test

54400

Insertion of penile prosthesis; non-inflatable( semi-rigid)

54401

Insertion of penile prosthesis;inflatable (self contained)

54405

Insertion of(multi-compnent), inflatable penile prosthesis, including placement of pump , cylinders, and reservoir

54406

Removal of all components of a multi-component, inflatable penile prosthesis without replacement of prosthesis

54408

Repair of component(s) of a multi-component, inflatable penile prosthesis

54410

Removal and replacement of component(s) of a multi-component, inflatable penile prosthesis at the same operative session

54411

Removal and replacement of all component(s) of a multi-component inflatable penile prosthesis through an infected field at the same operative session including irrigation and debridement of infected tissue

54415

Removal of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis, without replacement of prosthesis

54416

Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis at the same operative session

54417

Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis through an infected field at the same operative session including irrigation and debridement of infected tissue

74445

Corpora Cavernosography, Radiological Supervision And Interpretation.

84402

Testosterone; free

84403

Testosterone; total

84410

Testosterone; Bioavailable, Direct Measurement (eg, Differential Precipitation).

93975

Duplex Scan Of Arterial Inflow And Venous Outflow Of Abdominal, Pelvic, Scrotal Contents And/or Retroperitoneal Organs; Complete Study.

93976

Duplex Scan Of Arterial Inflow And Venous Outflow Of Abdominal, Pelvic, Scrotal Contents And/or Retroperitoneal Organs; Limited Study.

93980

Duplex Scan Of Arterial Inflow And Venous Outflow Of Penile Vessels; Complete Study.

93981

Duplex Scan Of Arterial Inflow And Venous Outflow Of Penile Vessels; Follow-up Or Limited Study.

J0270

Injection, Alprostadil, 1.25 Mcg(code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

J0275

Alprostadil Urethral Suppository code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

L7900

Vacuum erection system

L7902

Tension ring, for vacuum erection device, any type, replacement only, each

Eligible Diagnosis Codes for Procedure Codes 54115, 54205, 54230, 54231,54250, 54400, 54401, 54405, 54406, 54408, 54410, 54411, 54415, 54416, 54417  and 74445

 

 

N48.6

N50.1

N52.01 N52.02 N52.03

N52.1

N52.31 N52.32 N52.33 N52.34
N52.35 N52.36 N52.37 N52.39 N52.8
N52.9        

References

InterQual® Level of Care Criteria, 2021. Acute Care Adult. McKesson Health Solutions, LLC.

Johnsen NV, Kaufman MR, Dmochowski RR & Milam DF. Erectile dysfunction following pelvic fracture urethral injury. Sex Med Rev. 2018;6:114-123.

Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018). 2018. Accessed July 30, 2019.

Kayigil O, Okulu E, Akdemir F, Cakici OU. The combination of penile revascularization surgery with penile corrective techniques as an alternative to prosthesis implantation in patients with peyronie's disease accompanied by erectile dysfunction: Long-term results. Int J Impot Res. 2018;30(2):71-78.

Cosentino M, Bianco M, Ruiz-Castañé E, Iafrate M. Treatment of penile prosthesis implant's infection. Urol Int. 2020;104(7-8):542-545.

Verze P, Sokolakis I, Manfredi C, Collà Ruvolo C, Hatzichristodoulou G, Romero-Otero J. Penile prosthesis implant in the management of Peyronies' disease. Minerva Urol Nephrol. 2021;73(2):196-214.

Cosentino M, Bianco M, Ruiz-Castañé E, Iafrate M. Treatment of penile prosthesis implant's infection. Urol Int. 2020;104(7-8):542-545.

Segal RL, Siegelbaum MH, Lerner BD, Weinberg AC. inflatable penile prosthesis implantation in the ambulatory setting: A systematic review. Sex Med Rev. 2020;8(2):338-347.

Baas W, O'Connor B, Welliver C, et al. Worldwide trends in penile implantation surgery: Data from over 63,000 implants. Transl Androl Urol. 2020;9(1):31-37.

Akdemίr F, Kayıgίl Ö, Algın O, İpek A. The role of computerized tomography angiography in the management of cases undergoing penile revascularization due to erectile dysfunction: Prospective cohort study. BMC Med Imaging. 2022;22(1):217.

Chung E. A review of current and emerging therapeutic options for erectile dysfunction. Med Sci (Basel). 2019;7(9):91.

Ziegelmann MJ, Bajic P, Levine LA. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020;27(6):504-516.